Cell-based therapy for the treatment of glioblastoma (GBM) has gained a lot of attention as a minimally invasive drug delivery strategy because of its potential to overcome the blood-brain barrier (BBB) impediment and target the tumor microenvironment. Here, w... ...

请注册登录后继续浏览